Papers
1
Total Citations
14
H-Index
1
About
Valter Torri is a leading clinical researcher in surgical oncology, with a primary focus on optimizing treatment strategies for rectal cancer. His most impactful work centers on the timing of minimally-invasive surgery following neoadjuvant chemoradiotherapy—a critical question that directly influences patient outcomes. Torri’s landmark contribution is the TiMiSNAR trial, a multicenter randomized controlled study that compared standard 8-week versus prolonged 12-week intervals to surgery after chemoradiation. This rigorous investigation, cited 14 times, challenged conventional timelines by exploring whether extended waiting periods could enhance tumor regression and improve pathologic complete response rates. By providing high-level evidence on surgical timing, Torri’s research has helped refine clinical protocols, potentially reducing recurrence and sparing patients from more aggressive treatments. His work underscores a commitment to evidence-based surgical innovation, bridging the gap between retrospective observations and prospective validation. For students and researchers, Torri exemplifies how well-designed trials can resolve longstanding debates in oncology, directly shaping surgical practice and improving the quality of life for cancer patients.
Research Focus
Key Achievements
Top Papers
- 1